 | PHB | Name: | P-HYDROXYBENZOIC ACID | Formula: | C7 H6 O3 | SMILES: | O=C(O)c1ccc(O)cc1 | InChi: | InChI=1S/C7H6O3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H,(H,9,10) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 4-hydroxybenzoic acid |
|
 | P1K | Name: | phosphonooxy-[[4-[[2,2,2-tris(fluoranyl)ethylsulfonylamino]methyl]-1,2,3-triazol-1-yl]methyl]borinic acid | Formula: | C6 H11 B F3 N4 O7 P S | SMILES: | OB(Cn1cc(CN[S](=O)(=O)CC(F)(F)F)nn1)O[P](O)(O)=O | InChi: | InChI=1S/C6H11BF3N4O7PS/c8-6(9,10)3-23(19,20)11-1-5-2-14(13-12-5)4-7(15)21-22(16,17)18/h2,11,15H,1,3-4H2,(H2,16,17,18) | Definition date: | 2019-08-16 | Last modified: | 2024-09-27 | Release date: | 2020-06-24 | Identifier: | phosphonooxy-[[4-[[2,2,2-tris(fluoranyl)ethylsulfonylamino]methyl]-1,2,3-triazol-1-yl]methyl]borinic acid |
|
 | QPE | Name: | methyl (~{Z})-2-methyl-3-phenyl-prop-2-enoate | Formula: | C11 H12 O2 | SMILES: | COC(=O)C(C)=Cc1ccccc1 | InChi: | InChI=1S/C11H12O2/c1-9(11(12)13-2)8-10-6-4-3-5-7-10/h3-8H,1-2H3/b9-8- | Definition date: | 2020-07-16 | Last modified: | 2024-09-27 | Release date: | 2021-07-28 | Identifier: | methyl (~{Z})-2-methyl-3-phenyl-prop-2-enoate |
|
 | LCY | Name: | 1-methylpyrrolidine-2,5-dione | Formula: | C5 H7 N O2 | SMILES: | O=C1N(C(=O)CC1)C | InChi: | InChI=1S/C5H7NO2/c1-6-4(7)2-3-5(6)8/h2-3H2,1H3 | Definition date: | 2009-05-22 | Last modified: | 2024-09-27 | Identifier: | 1-methylpyrrolidine-2,5-dione |
|
 | P1L | Name: | S-PALMITOYL-L-CYSTEINE | Formula: | C19 H37 N O3 S | SMILES: | O=C(O)C(N)CSC(=O)CCCCCCCCCCCCCCC | InChi: | InChI=1S/C19H37NO3S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)24-16-17(20)19(22)23/h17H,2-16,20H2,1H3,(H,22,23)/t17-/m0/s1 | Definition date: | 2005-09-03 | Last modified: | 2024-09-27 | Identifier: | S-hexadecanoyl-L-cysteine |
|
 | LRK | Name: | (2S)-2-azanyl-6-[[(2R,4R)-1,4-bis(oxidanyl)-3-oxidanylidene-5-phosphonooxy-pentan-2-yl]amino]hexanoic acid | Formula: | C11 H23 N2 O9 P | SMILES: | O=P(OCC(O)C(=O)C(NCCCCC(C(=O)O)N)CO)(O)O | InChi: | InChI=1S/C11H23N2O9P/c12-7(11(17)18)3-1-2-4-13-8(5-14)10(16)9(15)6-22-23(19,20)21/h7-9,13-15H,1-6,12H2,(H,17,18)(H2,19,20,21)/t7-,8+,9+/m0/s1 | Definition date: | 2014-11-17 | Last modified: | 2024-09-27 | Release date: | 2015-01-14 | Identifier: | (2S)-2-amino-6-{[(2R,4R)-1,4-dihydroxy-3-oxo-5-(phosphonooxy)pentan-2-yl]amino}hexanoic acid (non-preferred name) |
|
 | 5OW | Name: | (2~{S})-2-azanyl-6-[[(~{Z})-~{C}-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]-~{N}-[(2~{R})-1-oxidanyl-1-oxidanylidene-3-sulfanyl-propan-2-yl]carbonimidoyl]amino]hexanoic acid | Formula: | C17 H27 N4 O9 P S | SMILES: | Cc1ncc(CO[P](O)(O)=O)c(c1O)C(NCCCC[CH](N)C(O)=O)=N[CH](CS)C(O)=O | InChi: | InChI=1S/C17H27N4O9PS/c1-9-14(22)13(10(6-20-9)7-30-31(27,28)29)15(21-12(8-32)17(25)26)19-5-3-2-4-11(18)16(23)24/h6,11-12,22,32H,2-5,7-8,18H2,1H3,(H,19,21)(H,23,24)(H,25,26)(H2,27,28,29)/t11-,12-/m0/s1 | Definition date: | 2015-10-30 | Last modified: | 2024-09-27 | Release date: | 2016-11-09 | Identifier: | (2~{S})-2-azanyl-6-[[(~{Z})-~{C}-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]-~{N}-[(2~{R})-1-oxidanyl-1-oxidanylidene-3-sulfanyl-propan-2-yl]carbonimidoyl]amino]hexanoic acid |
|
 | QPH | Name: | N-formyl-L-phenylalanine | Formula: | C10 H11 N O3 | SMILES: | O=C(O)C(NC=O)Cc1ccccc1 | InChi: | InChI=1S/C10H11NO3/c12-7-11-9(10(13)14)6-8-4-2-1-3-5-8/h1-5,7,9H,6H2,(H,11,12)(H,13,14)/t9-/m0/s1 | Definition date: | 2011-04-28 | Last modified: | 2024-09-27 | Identifier: | N-formyl-L-phenylalanine |
|
 | PHD | Name: | ASPARTYL PHOSPHATE | Formula: | C4 H8 N O7 P | SMILES: | O=C(OP(=O)(O)O)CC(C(=O)O)N | InChi: | InChI=1S/C4H8NO7P/c5-2(4(7)8)1-3(6)12-13(9,10)11/h2H,1,5H2,(H,7,8)(H2,9,10,11)/t2-/m0/s1 | Definition date: | 1999-10-06 | Last modified: | 2024-09-27 | Identifier: | 4-oxo-O-phosphono-L-homoserine |
|
 | V2K | Name: | 4-(5-methoxy-2-methyl-benzimidazol-1-yl)benzaldehyde | Formula: | C16 H14 N2 O2 | SMILES: | COc1ccc2n(c(C)nc2c1)c3ccc(C=O)cc3 | InChi: | InChI=1S/C16H14N2O2/c1-11-17-15-9-14(20-2)7-8-16(15)18(11)13-5-3-12(10-19)4-6-13/h3-10H,1-2H3 | Definition date: | 2021-04-08 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-(5-methoxy-2-methyl-benzimidazol-1-yl)benzaldehyde |
|
 | LD0 | Name: | (2R,4S,5R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-(sulfanylmethyl)-1,3-thiazinane-4-carboxylic acid | Formula: | C14 H19 N5 O5 S3 | SMILES: | SCC1CSC(NC1C(=O)O)C(C=O)NC(=O)C(=NOC)/c1csc(N)n1 | InChi: | InChI=1S/C14H19N5O5S3/c1-24-19-10(8-5-27-14(15)17-8)11(21)16-7(2-20)12-18-9(13(22)23)6(3-25)4-26-12/h2,5-7,9,12,18,25H,3-4H2,1H3,(H2,15,17)(H,16,21)(H,22,23)/b19-10-/t6-,7-,9+,12-/m1/s1 | Definition date: | 2022-03-01 | Last modified: | 2024-09-27 | Release date: | 2022-05-25 | Identifier: | (2R,4S,5R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-(sulfanylmethyl)-1,3-thiazinane-4-carboxylic acid |
|
 | 5OX | Name: | (7E,11Z,14Z,17Z,20Z)-5-oxotricosa-7,11,14,17,20-pentaenoic acid | Formula: | C23 H34 O3 | SMILES: | O=C(O)CCCC(=O)C[C@H]=[C@H]CC[C@H]=[C@H]C[C@H]=[C@H]C[C@H]=CCC=C/CC | InChi: | InChI=1S/C23H34O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19-22(24)20-18-21-23(25)26/h3-4,6-7,9-10,12-13,16-17H,2,5,8,11,14-15,18-21H2,1H3,(H,25,26)/b4-3-,7-6-,10-9-,13-12-,17-16+ | Definition date: | 2014-11-26 | Last modified: | 2024-09-27 | Release date: | 2015-04-08 | Identifier: | (7E,11Z,14Z,17Z,20Z)-5-oxotricosa-7,11,14,17,20-pentaenoic acid |
|
 | PHE | Name: | PHENYLALANINE | Formula: | C9 H11 N O2 | SMILES: | O=C(O)C(N)Cc1ccccc1 | InChi: | InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | L-phenylalanine |
|
 | TJ7 | Name: | (2R,4S)-2-[(1S)-1-{[(2R)-2-carboxy-2-(thiophen-3-yl)acetyl]amino}-1-methoxy-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4
-carboxylic acid | Formula: | C16 H20 N2 O7 S2 | SMILES: | O=CC(OC)(C1SC(C(N1)C(O)=O)(C)C)NC(=O)C(C(O)=O)c2cscc2 | InChi: | InChI=1S/C16H20N2O7S2/c1-15(2)10(13(23)24)17-14(27-15)16(7-19,25-3)18-11(20)9(12(21)22)8-4-5-26-6-8/h4-7,9-10,14,17H,1-3H3,(H,18,20)(H,21,22)(H,23,24)/t9-,10+,14-,16+/m1/s1 | Synonyms: | temocillin | Definition date: | 2019-10-15 | Last modified: | 2024-09-27 | Release date: | 2019-10-30 | Identifier: | (2R,4S)-2-[(1S)-1-{[(2R)-2-carboxy-2-(thiophen-3-yl)acetyl]amino}-1-methoxy-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
 | V2M | Name: | N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide | Formula: | C24 H34 N4 O6 | SMILES: | COc1cccc2[NH]c(cc12)C(=O)NC(CC(C)C)C(=O)NC(CC1CCNC1=O)C(O)CO | InChi: | InChI=1S/C24H34N4O6/c1-13(2)9-18(23(32)27-17(20(30)12-29)10-14-7-8-25-22(14)31)28-24(33)19-11-15-16(26-19)5-4-6-21(15)34-3/h4-6,11,13-14,17-18,20,26,29-30H,7-10,12H2,1-3H3,(H,25,31)(H,27,32)(H,28,33)/t14-,17-,18-,20+/m0/s1 | Synonyms: | N-[(2S)-1-({(2S)-4-hydroxy-3-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide, bound form | Definition date: | 2020-06-19 | Last modified: | 2024-09-27 | Release date: | 2020-07-08 | Identifier: | N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide |
|
 | LRN | Name: | 1-[(3R)-3-{(cyclohexylmethyl)[(1r,4R)-4-hydroxycyclohexyl]amino}piperidin-1-yl]ethan-1-one | Formula: | C20 H36 N2 O2 | SMILES: | O=C(C)N1CCCC(C1)N(CC1CCCCC1)C1CCC(O)CC1 | InChi: | InChI=1S/C20H36N2O2/c1-16(23)21-13-5-8-19(15-21)22(14-17-6-3-2-4-7-17)18-9-11-20(24)12-10-18/h17-20,24H,2-15H2,1H3/t18-,19-,20-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2024-09-27 | Release date: | 2023-11-08 | Identifier: | 1-[(3R)-3-{(cyclohexylmethyl)[(1r,4R)-4-hydroxycyclohexyl]amino}piperidin-1-yl]ethan-1-one |
|
 | TJ8 | Name: | 2-bromanyl-4-(2-phenylimidazol-1-yl)benzaldehyde | Formula: | C16 H11 Br N2 O | SMILES: | Brc1cc(ccc1C=O)n2ccnc2c3ccccc3 | InChi: | InChI=1S/C16H11BrN2O/c17-15-10-14(7-6-13(15)11-20)19-9-8-18-16(19)12-4-2-1-3-5-12/h1-11H | Synonyms: | LvD1009 | Definition date: | 2020-12-22 | Last modified: | 2024-09-27 | Release date: | 2021-06-16 | Identifier: | 2-bromanyl-4-(2-phenylimidazol-1-yl)benzaldehyde |
|
 | QPJ | Name: | 2-deoxy-3,5-di-O-phosphono-D-erythro-pentitol | Formula: | C5 H14 O10 P2 | SMILES: | P(O)(O)(OCC(O)C(CCO)OP(O)(O)=O)=O | InChi: | InChI=1S/C5H14O10P2/c6-2-1-5(15-17(11,12)13)4(7)3-14-16(8,9)10/h4-7H,1-3H2,(H2,8,9,10)(H2,11,12,13)/t4-,5+/m1/s1 | Definition date: | 2019-12-05 | Last modified: | 2024-09-27 | Release date: | 2022-03-09 | Identifier: | 2-deoxy-3,5-di-O-phosphono-D-erythro-pentitol |
|
 | WCR | Name: | [(2R,4Z)-2-(aminomethyl)-2-hydroxy-4-(4-hydroxybenzylidene)-5-oxoimidazolidin-1-yl]acetic acid | Formula: | C13 H15 N3 O5 | SMILES: | O=C(O)CN1C(=O)/C(NC1(O)CN)=C/c2ccc(O)cc2 | InChi: | InChI=1S/C13H15N3O5/c14-7-13(21)15-10(12(20)16(13)6-11(18)19)5-8-1-3-9(17)4-2-8/h1-5,15,17,21H,6-7,14H2,(H,18,19)/b10-5-/t13-/m1/s1 | Definition date: | 2011-07-18 | Last modified: | 2024-09-27 | Identifier: | [(2R,4Z)-2-(aminomethyl)-2-hydroxy-4-(4-hydroxybenzylidene)-5-oxoimidazolidin-1-yl]acetic acid |
|
 | V2N | Name: | 4-(6-methoxy-2-methyl-benzimidazol-1-yl)benzaldehyde | Formula: | C16 H14 N2 O2 | SMILES: | COc1ccc2nc(C)n(c3ccc(C=O)cc3)c2c1 | InChi: | InChI=1S/C16H14N2O2/c1-11-17-15-8-7-14(20-2)9-16(15)18(11)13-5-3-12(10-19)4-6-13/h3-10H,1-2H3 | Definition date: | 2021-04-08 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-(6-methoxy-2-methyl-benzimidazol-1-yl)benzaldehyde |
|
 | TXH | Name: | ~{tert}-butyl ~{N}-[(2~{S})-3-(1~{H}-indol-3-yl)-1-(2-methanoylhydrazinyl)-1-oxidanylidene-propan-2-yl]carbamate | Formula: | C17 H22 N4 O4 | SMILES: | CC(C)(C)OC(=O)N[CH](Cc1c[nH]c2ccccc12)C(=O)NNC=O | InChi: | InChI=1S/C17H22N4O4/c1-17(2,3)25-16(24)20-14(15(23)21-19-10-22)8-11-9-18-13-7-5-4-6-12(11)13/h4-7,9-10,14,18H,8H2,1-3H3,(H,19,22)(H,20,24)(H,21,23)/t14-/m0/s1 | Definition date: | 2023-01-13 | Last modified: | 2024-09-27 | Release date: | 2023-01-25 | Identifier: | ~{tert}-butyl ~{N}-[(2~{S})-3-(1~{H}-indol-3-yl)-1-(2-methanoylhydrazinyl)-1-oxidanylidene-propan-2-yl]carbamate |
|
 | TXI | Name: | (2R)-N-(4-chloro-3-oxobutyl)-2,4-dihydroxy-3,3-dimethylbutanamide | Formula: | C10 H18 Cl N O4 | SMILES: | O=C(NCCC(=O)CCl)C(O)C(C)(C)CO | InChi: | InChI=1S/C10H18ClNO4/c1-10(2,6-13)8(15)9(16)12-4-3-7(14)5-11/h8,13,15H,3-6H2,1-2H3,(H,12,16)/t8-/m0/s1 | Definition date: | 2011-09-06 | Last modified: | 2024-09-27 | Identifier: | (2R)-N-(4-chloro-3-oxobutyl)-2,4-dihydroxy-3,3-dimethylbutanamide |
|
 | QAC | Name: | N-[4-(hydroxymethyl)benzoyl]-beta-alanine | Formula: | C11 H13 N O4 | SMILES: | O=C(O)CCNC(=O)c1ccc(cc1)CO | InChi: | InChI=1S/C11H13NO4/c13-7-8-1-3-9(4-2-8)11(16)12-6-5-10(14)15/h1-4,13H,5-7H2,(H,12,16)(H,14,15) | Definition date: | 2014-10-01 | Last modified: | 2024-09-27 | Release date: | 2014-12-03 | Identifier: | N-[4-(hydroxymethyl)benzoyl]-beta-alanine |
|
 | TJB | Name: | 2-chloranyl-4-(2-phenylimidazol-1-yl)benzaldehyde | Formula: | C16 H11 Cl N2 O | SMILES: | Clc1cc(ccc1C=O)n2ccnc2c3ccccc3 | InChi: | InChI=1S/C16H11ClN2O/c17-15-10-14(7-6-13(15)11-20)19-9-8-18-16(19)12-4-2-1-3-5-12/h1-11H | Synonyms: | LvD1017 | Definition date: | 2020-12-22 | Last modified: | 2024-09-27 | Release date: | 2021-06-16 | Identifier: | 2-chloranyl-4-(2-phenylimidazol-1-yl)benzaldehyde |
|
 | PHI | Name: | IODO-PHENYLALANINE | Formula: | C9 H10 I N O2 | SMILES: | Ic1ccc(cc1)CC(C(=O)O)N | InChi: | InChI=1S/C9H10INO2/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 4-iodo-L-phenylalanine |
|